Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.
About
C4 Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of medicines for the treatment of cancer and other diseases. They leverage their proprietary drug discovery platform to design and synthesize small molecules that selectively engage the body's protein degradation machinery to target and eliminate disease-causing proteins.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does C4 Therapeutics do?
C4 Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of medicines for the treatment of cancer and other diseases. They leverage their proprietary drug discovery platform to design and synthesize small molecules that selectively engage the body's protein degradation machinery to target and eliminate disease-causing proteins.
How much funding has C4 Therapeutics raised?
C4 Therapeutics has raised a total of $371M in funding. The most recent round on record is Series D.
Where is C4 Therapeutics headquartered?
C4 Therapeutics is headquartered in Boston, United States.
When was C4 Therapeutics founded?
C4 Therapeutics was founded in 2016.
What industry does C4 Therapeutics operate in?
C4 Therapeutics operates in Biotech, Drug Discovery, Oncology, Clinical Trials, Protein Degradation, Small Molecules.